IQGAP1 in podosomes/invadosomes is involved in the progression of glioblastoma multiforme depending on the tumor status

International Journal of Molecular Sciences

Volumn 18, Issue 1, 2017, Pages

  Rotoli, Deborah ^a,b   Pérez Rodríguez, Natalia Dolores ^c   Morales, Manuel ^c,d   Maeso, María Del Carmen ^c   Ávila, Julio ^a   Mobasheri, Ali ^e,f   Martín Vasallo, Pablo ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b CNR   (Italy)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d Grupo Hospiten   (Spain)

^e UNIVERSITY OF SURREY   (United Kingdom)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Glioblastoma multiforme (GBM); IQGAP1; Podosome invadosome; Scaffold protein

Indexed keywords

IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; TUMOR MARKER;

ARTICLE; CANCER PROGNOSIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MALE; OVERALL SURVIVAL; PODOSOME; PROTEIN INTERACTION; TUMOR GROWTH; BIOLOGICAL MODEL; DISEASE COURSE; METABOLISM; PATHOLOGY;

BIOMARKERS, TUMOR; DISEASE PROGRESSION; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MODELS, BIOLOGICAL; PODOSOMES; RAS GTPASE-ACTIVATING PROTEINS;

EID: 85009887731     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18010150     Document Type: Article

References (51)

1. Lacroix, M.; Abi-Said, D.; Fourney, D.R.; Gokaslan, Z.L.; Shi,W.; DeMonte, F.; Lang, F.F.; McCutcheon, I.E.; Hassenbusch, S.J.; Holland, E.; et al. A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J. Neurosurg. 2001, 95, 190-198. [CrossRef] [PubMed]
2. Riemenschneider, M.J.; Reifenberger, G. Molecular neuropathology of gliomas. Int. J. Mol. Sci. 2009, 10, 184-212. [CrossRef] [PubMed]
3. Stupp, R.; Mason, W.P.; van den Bent, M.J.; Weller, M.; Fisher, B.; Taphoorn, M.J.; Belanger, K.; Brandes, A.A.; Marosi, C.; Bogdahn, U.; et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352, 987-996. [CrossRef] [PubMed]
4. Galanis, E.; Wu, W.; Sarkaria, J.; Chang, S.M.; Colman, H.; Sargent, D.; Reardon, D.A. Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments. Curr. Oncol. Rep. 2011, 13, 42-49. [CrossRef] [PubMed]
5. Hegi, M.E.; Diserens, A.C.; Gorlia, T.; Hamou, M.F.; de Tribolet, N.; Weller, M.; Kros, J.M.; Hainfellner, J.A.; Mason,W.; Mariani, L.; et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 2005, 352, 997-1003. [CrossRef] [PubMed]
6. Nicolaides, T.P.; Li, H.; Solomon, D.A.; Hariono, S.; Hashizume, R.; Barkovich, K.; Baker, S.J.; Paugh, B.S.; Jones, C.; Forshew, T.; et al. Targeted therapy for BRAFV600E malignant astrocytoma. Clin. Cancer Res. 2011, 17, 7595-7604. [CrossRef] [PubMed]
7. Von Daimling, A.; Korshunov, A.; Hartmann, C. The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations. Brain Pathol. 2011, 21, 74-87. [CrossRef] [PubMed]
8. Erickson, J.W.; Cerione, R.A.; Hart, M.J. Identification of an actin cytoskeletal complex that includes IQGAP and the Cdc42 GTPase. J. Biol. Chem. 1997, 272, 24443-24447. [CrossRef] [PubMed]
9. Roy, M.; Li, Z.; Sacks, D.B. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling. Mol. Cell. Biol. 2005, 25, 7940-7952. [CrossRef] [PubMed]
10. White, C.D.; Erdemir, H.H.; Sacks, D.B. IQGAP1 and its binding proteins control diverse biological functions. Cell Signal. 2012, 24, 826-834. [CrossRef] [PubMed]
11. Malarkannan, S.; Awasthi, A.; Rajasekaran, K.; Kumar, P.; Schuldt, K.M.; Bartoszek, A.; Manoharan, N.; Goldner, N.K.; Umhoefer, C.M.; Thakar, M.S. IQGAP1: A regulator of intracellular spacetime relativity. J. Immunol. 2012, 188, 2057-2063. [CrossRef] [PubMed]
12. Johnson, M.; Sharma, M.; Henderson, B.R. IQGAP1 regulation and roles in cancer. Cell Signal. 2009, 21, 1471-1478. [CrossRef] [PubMed]
13. White, C.D.; Brown, M.D.; Sacks, D.B. IQGAPs in cancer: A family of scaffold proteins underlying tumorigenesis. FEBS Lett. 2009, 583, 1817-1824. [CrossRef] [PubMed]
14. Nabeshima, K.; Shimao, Y.; Inoue, T.; Koono, M. Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: Its overexpression in carcinomas and association with invasion fronts. Cancer Lett. 2002, 176, 101-109. [CrossRef]
15. Rotoli, D.;Morales,M.; del Carmen,M.M.; del Pino, G.M.; Gutierrez, R.; Valladares, F.; Avila, J.; Díaz-Flores, L.; Mobasheri, A.; Martin-Vasallo, P. Alterations in IQGAP1 expression and localization in colorectal carcinoma and liver metastases following oxaliplatin-based chemotherapy. Oncol. Lett. 2017, in press.
16. McDonald, K.L.; O’Sullivan, M.G.; Parkinson, J.F.; Shaw, J.M.; Payne, C.A.; Brewer, J.M.; Young, L.; Reader, D.J.; Wheeler, H.T.; Cook, R.J.; et al. IQGAP1 and IGFBP2: Valuable biomarkers for determining prognosis in glioma patients. J. Neuropathol. Exp. Neurol. 2007, 66, 405-417. [CrossRef] [PubMed]
17. Kim, S.J.; Kim, J.S.; Papadopoulos, J.;Wook, K.S.; Maya, M.; Zhang, F.; He, J.; Fan, D.; Langley, R.; Fidler, I.J. Circulating monocytes expressing CD31: Implications for acute and chronic angiogenesis. Am. J. Pathol. 2009, 174, 1972-1980. [CrossRef] [PubMed]
18. Zhou, W.; Bao, S. Reciprocal Supportive Interplay between Glioblastoma and Tumor-Associated Macrophages. Cancers (Basel) 2014, 6, 723-740. [CrossRef] [PubMed]
19. Zhou, W.; Ke, S.Q.; Huang, Z.; Flavahan, W.; Fang, X.; Paul, J.; Wu, L.; Sloan, A.E.; McLendon, R.E.; Li, X.; et al. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat. Cell Biol. 2015, 17, 170-182. [CrossRef] [PubMed]
20. Shi, Y.; Ping, Y.F.; Zhang, X.; Bian, X.W. Hostile takeover: Glioma stem cells recruit TAMs to support tumor progression. Cell Stem Cell 2015, 16, 219-220. [CrossRef] [PubMed]
21. Dell’Albani, P. Stem cell markers in gliomas. Neurochem. Res. 2008, 33, 2407-2415. [CrossRef] [PubMed]
22. Jin, X.; Jin, X.; Jung, J.E.; Beck, S.; Kim, H. Cell surface Nestin is a biomarker for glioma stem cells. Biochem. Biophys. Res. Commun. 2013, 433, 496-501. [CrossRef] [PubMed]
23. Wang, L.; Zhang, L.; Shen, W.; Liu, Y.; Luo, Y. High expression of VEGF and PI3K in glioma stem cells provides new criteria for the grading of gliomas. Exp. Ther. Med. 2016, 11, 571-576. [CrossRef] [PubMed]
24. Wiese, C.; Rolletscheck, A.; Kania, G.; Blyszczuk, P.; Tarasov, K.V.; Tarasova, Y.;Wersto, R.P.; Boheler, K.R.; Wobus, A.M. Nestin expression-A property of multi-lineage progenitor cells? Cell. Mol. Life Sci. 2004, 61, 2510-2522. [CrossRef] [PubMed]
25. Neradil, J.; Veselska, R. Nestin as a marker of cancer stem cells. Cancer Sci. 2015, 106, 803-811. [CrossRef] [PubMed]
26. Bradshaw, A.; Wickremsekera, A.; Tan, S.T.; Peng, L.; Davis, P.F.; Itinteang, T. Cancer Stem Cell Hierarchy in Glioblastoma Multiforme. Front. Surg. 2016, 3, 21. [CrossRef] [PubMed]
27. Branch, K.M.; Hoshino, D.;Weaver, A.M. Adhesion rings surround invadopodia and promote maturation. Biol. Open 2012, 1, 711-722. [CrossRef] [PubMed]
28. 2+-signaling molecules expressed in podosomes. J. Neuroinflamm. 2012, 9, 250. [CrossRef] [PubMed]
29. Díaz-Flores, L.; Gutiérrez, R.; Madrid, J.F.; Varela, H.; Valladares, F.; Acosta, E.; Martín-Vasallo, P.; Díaz-Flores, L., Jr. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol. Histopatol. 2009, 4, 909-969.
30. Wesseling, P.; Schlingemann, R.O.; Rietveld, F.J.; Link, M.; Burger, P.C.; Ruiter, D.J. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: An immuno-light and immuno-electron microscopic study. J. Neuropathol. Exp. Neurol. 1995, 54, 304-310. [CrossRef] [PubMed]
31. Moldovan, G.L.; Pfander, B.; Jentsch, S. PCNA, the maestro of the replication fork. Cell 2007, 129, 665-679. [CrossRef] [PubMed]
32. Johnson, M.; Sharma, M.; Brocardo, M.G.; Henderson, B.R. IQGAP1 translocates to the nucleus in early S-phase and contributes to cell cycle progression after DNA replication arrest. Int. J. Biochem. Cell Biol. 2011, 43, 65-73. [CrossRef] [PubMed]
33. Balenci, L.; Clarke, I.D.; Dirks, P.B.; Assard, N.; Ducray, F.; Jouvet, A.; Belin, M.F.; Honnorat, J.; Baudier, J. IQGAP1 protein specifies amplifying cancer cells in glioblastoma multiforme. Cancer Res. 2006, 66, 9074-9082. [CrossRef] [PubMed]
34. Adams, J.M.; Strasser, A. Is Tumor Growth Sustained by Rare Cancer Stem Cell Or Dominant Clones? Cancer Res. 2008, 68, 4018-4021. [CrossRef] [PubMed]
35. Coniglio, S.J.; Segall, J.E. Review: Molecular mechanism of microglia stimulated glioblastoma invasion. Matrix Biol. 2013, 32, 372-380. [CrossRef] [PubMed]
36. Alves, T.R.; Lima, F.R.; Kahn, S.A.; Lobo, D.; Dubois, L.G.; Soletti, R.; Borges, H.; Neto, V.M. Glioblastoma cells: A heterogeneous and fatal tumor interacting with the parenchyma. Life Sci. 2011, 89, 532-539. [CrossRef] [PubMed]
37. Li, W.; Graeber, M.B. The molecular profile of microglia under the influence of glioma. Neuro Oncol. 2012, 14, 958-978. [CrossRef] [PubMed]
38. Charles, N.A.; Holland, E.C.; Gilbertson, R.; Glass, R.; Kettenmann, H. The brain tumor microenvironment. Glia 2012, 60, 502-514. [CrossRef] [PubMed]
39. Rezaie, P.; Patel, K.; Male, D.K. Microglia in the human fetal spinal cord-Patterns of distribution, morphology and phenotype. Dev. Brain Res. 1999, 115, 71-81. [CrossRef]
40. Ye, X.Z.; Xu, S.L.; Xin, Y.H.; Yu, S.C.; Ping, Y.F.; Chen, L.; Xiao, H.L.; Wang, B.; Yi, L.; Wang, Q.L.; et al. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J. Immunol. 2012, 189, 444-453. [CrossRef] [PubMed]
41. Iwadate, Y. Epithelial-mesenchymal transition in glioblastoma progression. Oncol. Lett. 2016, 11, 1615-1620. [CrossRef] [PubMed]
42. Rahmathulla, G.; Toms, S.A.;Weil, R.J. The molecular biology of brain metastasis. J. Oncol. 2012, 2012, 723541. [CrossRef] [PubMed]
43. Huysentruyt, L.C.; Mukherjee, P.; Banerjee, D.; Shelton, L.M.; Seyfried, T.N. Metastatic cancer cells with macrophage properties: Evidence from a new murine tumor model. Int. J. Cancer 2008, 123, 73-84. [CrossRef] [PubMed]
44. Zhou, Y.;Wu, S.; Liang, C.; Lin, Y.; Zou, Y.; Li, K.; Lu, B.; Shu, M.; Huang, Y.; Zhu,W.; et al. Transcriptional upregulation of microtubule-associated protein 2 is involved in the protein kinase A-induced decrease in the invasiveness of glioma cells. Neuro Oncol. 2015, 17, 1578-1588. [CrossRef] [PubMed]
45. Seano, G.; Chiaverina, G.; Gagliardi, P.A.; di, B.L.; Puliafito, A.; Bouvard, C.; Sessa, R.; Tarone, G.; Sorokin, L.; Helley, D.; et al. Endothelial podosome rosettes regulate vascular branching in tumour angiogenesis. Nat. Cell Biol. 2014, 16, 931-938. [CrossRef] [PubMed]
46. Gimona, M.; Buccione, R.; Courtneidge, S.A.; Linder, S. Assembly and biological role of podosomes and invadopodia. Curr. Opin. Cell Biol. 2008, 20, 235-241. [CrossRef] [PubMed]
47. Genot, E.; Gligorijevic, B. Invadosomes in their natural habitat. Eur. J. Cell Biol. 2014, 93, 367-379. [CrossRef] [PubMed]
48. Hoshino, D.; Branch, K.M.; Weaver, A.M. Signaling inputs to invadopodia and podosomes. J. Cell Sci. 2013, 126, 2979-2989. [CrossRef] [PubMed]
49. Poincloux, R.; Lizarraga, F.; Chavrier, P. Matrix invasion by tumour cells: A focus on MT1-MMP trafficking to invadopodia. J. Cell Sci. 2009, 122, 3015-3024. [CrossRef] [PubMed]
50. Lu, S.H.; Jiang, X.J.; Xiao, G.L.; Liu, D.Y.; Yuan, X.R. miR-124a restoration inhibits glioma cell proliferation and invasion by suppressing IQGAP1 and beta-catenin. Oncol. Rep. 2014, 32, 2104-2110. [PubMed]
51. Rotoli, D.; Morales, M.; del Carmen, M.M.; del Pino, G.M.; Morales, A.; Avila, J.; Martin-Vasallo, P. Expression and localization of the immunophilin FKBP51 in colorectal carcinomas and primary metastases, and alterations following oxaliplatin-based chemotherapy. Oncol. Lett. 2016, 12, 1315-1322. [CrossRef] [PubMed]